GlassScriptPhysician profile
Trenton Overall
NPI 1841575032
$7,787.11
in general payments reported to CMS, 2019-2025
38 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $898 · 2020: $286 · 2021: $1,481 · 2022: $2,289 · 2023: $2,502 · 2024: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,647 · Travel and Lodging: $1,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,646.74 |
| Travel and Lodging | $1,186.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $1,216.47 | 2023 | Stimrouter Implantable Kit |
| Medtronic USA, INC. | $1,169.70 | 2019-2020 | |
| Biogen, INC. | $883.54 | 2021-2024 | Vumerity, Tysabri |
| Abbvie INC. | $845.99 | 2021-2024 | |
| Emd Serono, INC. | $421.13 | 2022-2023 | Mavenclad |
| Medtronic, INC. | $396.61 | 2021-2023 | Percept PC Brainsense |
| Novartis Pharmaceuticals Corporation | $312.00 | 2021-2024 | |
| Amgen INC. | $242.25 | 2021-2023 | Aimovig |
| Sk Life Science, INC. | $237.05 | 2021-2024 | |
| Lundbeck LLC | $220.08 | 2021-2024 | Vyepti, Rexulti |
| Biohaven Pharmaceuticals, INC. | $185.21 | 2021 | |
| Eisai INC. | $184.68 | 2021-2023 | |
| Teva Pharmaceuticals USA, INC. | $180.72 | 2021-2024 | Ajovy, Austedo Xr |
| Allergan, INC. | $129.14 | 2021-2022 | |
| Genentech USA, INC. | $121.31 | 2021-2023 | Enspryng, Ocrevus |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trenton Overall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.